Showing results (1-10 of 338) with videos related to
Sort By:
Pageof 34
Current Protocols in Pharmacology|February 26, 2019
Preclinical Models of Alzheimer's Disease: Relevance and Translational ValidityKevin Mullane, Michael WilliamsBiochemical Pharmacology|October 2, 2018
Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeuticsKevin Mullane, Michael WilliamsBiochemical Pharmacology|July 9, 2013
Animal models of asthma: reprise or reboot?Kevin Mullane, Michael WilliamsBiochemical Pharmacology|April 12, 2017
Enhancing reproducibility: Failures from Reproducibility Initiatives underline core challengesKevin Mullane, Michael WilliamsDrug Discovery Today|January 25, 2012
Translational semantics and infrastructure: another search for the emperor's new clothes?Kevin Mullane, Michael WilliamsBiochemical Pharmacology|August 5, 2015
Unknown unknowns in biomedical research: does an inability to deal with ambiguity contribute to issues of irreproducibility?Kevin Mullane, Michael WilliamsBiochemical Pharmacology|April 6, 2020
Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?Kevin Mullane, Michael WilliamsBiochemical Pharmacology|October 2, 2018
Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causalityKevin Mullane, Michael WilliamsCurrent Opinion in Pharmacology|February 24, 2019
The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeuticsKevin Mullane, Michael WilliamsBiochemical Pharmacology|November 27, 2012
Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?Kevin Mullane, Michael WilliamsPageof 34